Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rituximab (RTx)”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Testing effectiveness (Phase 2)Study completedNCT01136395
What this trial is testing

Impact of Rituximab (RTx) Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation

Who this might be right for
Kidney TransplantationRituximab (RTx)Living Donors+2 more
University of Giessen 85
Testing effectiveness (Phase 2)Study completedNCT02900976
What this trial is testing

Rituximab and LMP-Specific T-Cells in Treating Pediatric Solid Organ Recipients With EBV-Positive, CD20-Positive Post-Transplant Lymphoproliferative Disorder

Who this might be right for
EBV-Related Post-Transplant Lymphoproliferative DisorderMonomorphic Post-Transplant Lymphoproliferative DisorderPolymorphic Post-Transplant Lymphoproliferative Disorder+4 more
Children's Oncology Group 18
Post-approval studies (Phase 4)Looking for participantsNCT06906549
What this trial is testing

Evaluation of 200 mg of Rituximab Every 6 Months as Maintenance Treatment of Rituximab-treated Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)Rituximab (RTx)
University Hospital, Strasbourg, France 260
Not applicableActive Not RecruitingNCT06949241
What this trial is testing

A Single Cycle of Intravenous Immunoglobulin as Adjuvant to Rituximab in Patients With Pemphigus: A Retrospective Cohort Study at a Tertiary Referral Center

Who this might be right for
Pemphigus DiseaseRituximab (RTx)Intravenous Immunoglobulin
Ruijin Hospital 76
Early research (Phase 1)Study completedNCT00366418
What this trial is testing

Lower But More Frequent Dose Rituximab to Treat Chronic Lymphocytic Leukemia

Who this might be right for
Refractory Chronic Lymphocytic Leukemia
National Heart, Lung, and Blood Institute (NHLBI) 4
Very early researchNot Yet RecruitingNCT07769333
What this trial is testing

Rituximab With Corticosteroids Versus Corticosteroids Plus Azathioprine for Moderate-to-Severe Pemphigus Vulgaris

Who this might be right for
Pemphigus VulgarisRituximab (RTx)
Khyber Teaching Hospital 92
Early research (Phase 1)Looking for participantsNCT07225439
What this trial is testing

Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

Who this might be right for
Non Hodgkin LymphomaB-cell Non Hodgkin LymphomaDiffuse Large B Cell Lymphoma+7 more
Paolo Caimi, MD 15
Large-scale testing (Phase 3)Study completedNCT01332994
What this trial is testing

RoActemra/Actemra and, if Initially Inadequately Responded to RoActemra/Actemra, Followed by MabThera/Rituxan in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 519
Not applicableStudy completedNCT07457944
What this trial is testing

Efficacy and Safety of Different Doses of Rituximab Therapy in Pemphigus Patients

Who this might be right for
Pemphigus DiseaseRituximab (RTx)
Ruijin Hospital 275
Early research (Phase 1)Study completedNCT06186219
What this trial is testing

Recapturing Immune Tolerance to Pegloticase for the Management of Tophaceous Gout

Who this might be right for
Tophaceous Gout
University of California, Los Angeles 2
Testing effectiveness (Phase 2)UnknownNCT00892827
What this trial is testing

Combined Treatment With Fresh Frozen Plasma and Rituximab (Mabthera) in Patients With Advanced Refractory Chronic Lymphocytic Leukemia

Who this might be right for
Advanced Refractory Chronic Lymphocytic Leukemia
Wolfson Medical Center 10
Large-scale testing (Phase 3)UnknownNCT02834468
What this trial is testing

DEX Combined With RTX, CSA and IVIG in the Management of Newly Diagnosed ITP Patients

Who this might be right for
Immune Thrombocytopenia
Shandong University 100
Post-approval studies (Phase 4)Study completedNCT02731560
What this trial is testing

Rituximab (RTX) for Disease Modifying Anti Rheumatic Drug (DMARD) Non-responders in Pakistan: The Pakistan Rituximab Study (PARIS)

Who this might be right for
Rheumatoid Arthritis
Prof. Abid Z. Farooqi 74
Large-scale testing (Phase 3)Study completedNCT02763319
What this trial is testing

A Trial to Evaluate the Efficacy and Safety of Tafasitamab With Bendamustine (BEN) Versus Rituximab (RTX) With BEN in Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-cell Lymphoma
Incyte Corporation 453
Post-approval studies (Phase 4)Study completedNCT02378298
What this trial is testing

Rituximab (RTX) Therapy in Patients With Active TAO

Who this might be right for
Ophthalmopathy, Thyroid-Associated
Göteborg University 38
Testing effectiveness (Phase 2)Ended earlyNCT04402580
What this trial is testing

Efficacy of Anti-CD20 Antibodies (Rituximab Biosimilar) in the Treatment of Childhood Steroid-dependent Nephrotic Syndrome

Who this might be right for
Nephrotic Syndrome Steroid-Dependent
Istituto Giannina Gaslini 30
Testing effectiveness (Phase 2)Study completedNCT01584388
What this trial is testing

Rituximab in IgG4-RD: A Phase 1-2 Trial

Who this might be right for
Retroperitoneal FibrosisAutoimmune PancreatitisSialadenitis+1 more
Massachusetts General Hospital 30